Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

SB 542 (2023-2024)

https://ontology.bommaritollc.com/id/01a0d569-3bb6-72e3-b39f-ed4410a86f1d

adms:identifier	mi-legislature-measure 2023-2024/SB/542
dcterms:temporal	Michigan Legislature, 2023-2024 session
primary sponsor	Kevin Hertel
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0542 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0542 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0542
schema:legislationIdentifier	SB 542
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; choice of formulation, dosage, and route of administration for opioid antagonists by certain persons and governmental entities if department of health and human services distributes opioid antagonists free of charge; allow. Creates new act.en
schema:sponsor	Erika Geiss Stephanie Chang Darrin Camilleri Paul Wojno Kevin Hertel Rosemary Bayer Sue Shink Joseph N Bellino Jr. Sean McCann Mark E Huizenga
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0542
skos:prefLabel	SB 542 (2023-2024)en
status	reported
status date	2024-12-12xsd:date